That is the first investigation of B. coagulans MTCC 5856 as a single probiotic agent at a dose of two × 109 spores (cfu) per day which demonstrated efficacy and safety within the patients experiencing MDD symptoms with IBS. The each day meals intake of the patients was recorded in the patient diaries provided to them at Visit 1 (Day 0). The identical was ch...